The Second-Line Management of Idiopathic Overactive Bladder: What Is the Place of Sacral Neuromodulation and Botulinum Toxin-A in Contemporary Practice?
BJU International - United Kingdom
doi 10.1111/j.1464-410x.2009.08777.x
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 1, 2009
Authors
Publisher
Wiley